Femmenessence: Proven to Regulate Hormone Levels in Women
SAN FRANCISCO, June 12 /PRNewswire/ -- Women approaching and exiting menopause are in a bind. As hormone levels fluctuate and decline, they experience a range of uncomfortable symptoms that can include hot flashes, night sweats, mood decline, and loss of libido. As common as these symptoms are, women's options for relief are limited. Researchers reported in 2002 that the hormone replacement therapy Prempro(R), which introduces foreign estrogens, obtained from pregnant mare's urine, into a woman's body, increased rates of breast cancer and stroke, (per JAMA 2002; 288:321-333.) causing American women to reject the drug en masse. While natural products that promise relief from menopausal symptoms abound, few have success rates higher than 50% and none have been clinically proven to regulate hormone levels; with one exception: Natural Health International's Femmenessence, made from the proprietary ingredient Maca-GO(R), www.naturalhi.com, a concentrated organically certified, proprietary formulation of the Peruvian herb maca.
Hormones are the body's directors, controlling the activity of cells and organs, affecting much more than just menopausal symptoms. "Hormones are profoundly important to a woman's health - hormones affect a woman's mood and cognitive function, they directly affect a woman's bone density, and hormones are without a doubt the most important factor of a woman's cardiovascular health," explains James Frame, CEO of Natural Health International (NHI), a vertically integrated San Francisco based health and dietary supplement company.
The subject of four published studies, the Femmenessence line includes two hormone-balancing products for women entering or leaving "the change of life": MacaLife(R) for peri-menopausal women experiencing hormonal fluctuations, and MacaPause(R) for post-menopausal women experiencing loss of hormone production. Peri-menopause is the 1-10 year period in which a woman's body transitions into menopause.
Femmenessence does not introduce any foreign hormones into the system. It simply supports the body's ability to balance (either increase or decrease) levels of its own hormones. Passing stringent pharmacology, toxicology and double blind placebo controlled clinical trials for health and safety, Femmenessence is as safe and side effect-free as your own hormones have been throughout your life.
However, the products are very different to other Maca based products and are not interchangeable, both due to the concentrated levels of the full spectrum of active constituents, and multiple phenotypes. "Something a lot of people don't realize is that there are 13 different phenotypes within Maca, and amazingly some of those phenotypes actually elicit different physiological effects," said Frame. NHI researched what the different phenotypes do and formulated Femmenessence MacaLife(R) and Femmenessence MacaPause(R) accordingly. MacaLife(R) is formulated for relief of menopausal symptoms, while MacaPause(R) is focused on supporting foundational health after menopause, such as heart health, bone health, mental health and hormonal balance.
About Natural Health International
Natural Health International was founded in 1997 as a raw material supply business in Sydney, Australia, that today has expanded internationally and merged with a leading research and development company. One of the few dietary supplement companies in the world that is vertically integrated, NHI grows its own herbs and maintains complete control over the manufacturing and distribution of its products. All NHI products are packaged in oxygen-barrier blister packs, recycled light-proof cardboard boxes, and are printed with vegetable ink. NHI products are available through selected health food stores such as Whole Foods, PCC, NRG and Pharmaca, as well as online at www.naturalhi.com.
For more information on NHI, the Femmenessence product line, or media related inquiries, contact Jennifer Bryan 805-962-1347 or at firstname.lastname@example.org.
|SOURCE Natural Health International|
Copyright©2009 PR Newswire.
All rights reserved